F. Courbon

2.3k total citations
84 papers, 1.4k citations indexed

About

F. Courbon is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Epidemiology. According to data from OpenAlex, F. Courbon has authored 84 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Radiology, Nuclear Medicine and Imaging, 29 papers in Oncology and 24 papers in Epidemiology. Recurrent topics in F. Courbon's work include Medical Imaging Techniques and Applications (24 papers), Neuroendocrine Tumor Research Advances (21 papers) and Neuroblastoma Research and Treatments (19 papers). F. Courbon is often cited by papers focused on Medical Imaging Techniques and Applications (24 papers), Neuroendocrine Tumor Research Advances (21 papers) and Neuroblastoma Research and Treatments (19 papers). F. Courbon collaborates with scholars based in France, United Kingdom and United States. F. Courbon's co-authors include Philippe Rochaix, Slimane Zerdoud, Philippe Caron, I. Berry, Delphine Vezzosi, Christiane Susini, Jean‐Michel Sénard, Christine Brefel‐Courbon, Claire Thalamas and Olivier Rascol and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

F. Courbon

79 papers receiving 1.4k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
F. Courbon	553	495	490	386	256	84	1.4k
John J. Zaknun	491 0.9×	487 1.0×	273 0.6×	564 1.5×	211 0.8×	35	1.3k
Inga Buchmann	507 0.9×	461 0.9×	525 1.1×	788 2.0×	376 1.5×	49	1.8k
Christian Waldherr	894 1.6×	920 1.9×	568 1.2×	722 1.9×	306 1.2×	23	1.9k
David B. Mansur	210 0.4×	283 0.6×	301 0.6×	191 0.5×	421 1.6×	82	1.5k
Andrei Todica	384 0.7×	243 0.5×	144 0.3×	840 2.2×	460 1.8×	105	1.5k
Amir Sabet	1.1k 1.9×	1.1k 2.2×	790 1.6×	727 1.9×	427 1.7×	92	1.9k
Raffaella Barone	769 1.4×	916 1.9×	540 1.1×	792 2.1×	205 0.8×	23	1.5k
David A. Pattison	396 0.7×	334 0.7×	226 0.5×	453 1.2×	546 2.1×	82	1.4k
C. M. Carapella	402 0.7×	355 0.7×	196 0.4×	341 0.9×	843 3.3×	85	2.1k
Flavio Forrer	1.2k 2.2×	1.3k 2.6×	634 1.3×	1.4k 3.6×	485 1.9×	51	2.9k

Countries citing papers authored by F. Courbon

Since Specialization

Citations

This map shows the geographic impact of F. Courbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Courbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Courbon more than expected).

Fields of papers citing papers by F. Courbon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Courbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Courbon. The network helps show where F. Courbon may publish in the future.

Co-authorship network of co-authors of F. Courbon

This figure shows the co-authorship network connecting the top 25 collaborators of F. Courbon. A scholar is included among the top collaborators of F. Courbon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Courbon. F. Courbon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dierickx, Lawrence, et al.. (2024). Evaluation of a blood miRNA/mRNA signature to follow-up Lu-PRRT therapy for G1/G2 intestinal neuroendocrine tumors. Frontiers in Endocrinology. 15. 1385079–1385079. 2 indexed citations

Chaltiel, Léonor, et al.. (2024). Insertion of synthetic lesions on patient data: a method for evaluating clinical performance differences between PET systems. EJNMMI Physics. 11(1). 9–9. 1 indexed citations

Kennedy, John A., et al.. (2023). An extended bore length solid-state digital-BGO PET/CT system: design, preliminary experience, and performance characteristics. European Journal of Nuclear Medicine and Molecular Imaging. 51(4). 954–964. 7 indexed citations

Taprogge, J., Alex Vergara Gil, Francesca Leek, et al.. (2023). Normal organ dosimetry for thyroid cancer patients treated with radioiodine as part of the multi-centre multi-national Horizon 2020 MEDIRAD project. European Journal of Nuclear Medicine and Molecular Imaging. 50(11). 3225–3234. 4 indexed citations

Médina, Philippe de, Régis Soulès, Michel Record, et al.. (2023). The Cholesterol-5,6-Epoxide Hydrolase: A Metabolic Checkpoint in Several Diseases. Advances in experimental medicine and biology. 1440. 149–161. 1 indexed citations

Navalkissoor, Shaunak, Rajaventhan Srirajaskanthan, F. Courbon, et al.. (2022). Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective study. European Journal of Nuclear Medicine and Molecular Imaging. 49(10). 3529–3537. 14 indexed citations

Fiallo, Marina, et al.. (2018). Tissue-inspired phantoms: a new range of equivalent tissue simulating breast, cortical bone and lung tissue. Biomedical Physics & Engineering Express. 4(3). 35017–35017. 5 indexed citations

Oudard, Stéphane & F. Courbon. (2016). Controversies and consensus in the innovation access for cancer therapy in the European countries: on the subject of metastatic prostate cancer. Annals of Oncology. 28(2). 421–426. 1 indexed citations

Dercle, Laurent, Roland Chisin, Samy Ammari, et al.. (2014). Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: Are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?. European Journal of Nuclear Medicine and Molecular Imaging. 42(3). 397–408. 16 indexed citations

10.

Mestier, Louis de, Clarisse Dromain, Gaspard d’Assignies, et al.. (2013). Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art. Endocrine Related Cancer. 21(3). R105–R120. 59 indexed citations

11.

Médina, Philippe de, Michaël R. Paillasse, Grégory Segala, et al.. (2011). Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands. Chemistry and Physics of Lipids. 164(6). 432–437. 48 indexed citations

12.

Vergèz, S., Jean‐Pierre Delord, Fabienne Thomas, et al.. (2010). Preclinical and Clinical Evidence that Deoxy-2-[18F]fluoro- D -glucose Positron Emission Tomography with Computed Tomography Is a Reliable Tool for the Detection of Early Molecular Responses to Erlotinib in Head and Neck Cancer. Clinical Cancer Research. 16(17). 4434–4445. 20 indexed citations

13.

Delord, J.P., Stéphane Quideau, Philippe Rochaix, et al.. (2010). Trastuzumab induced in vivo tissue remodelling associated in vitro with inhibition of the active forms of AKT and PTEN and RhoB induction in an ovarian carcinoma model. British Journal of Cancer. 103(1). 61–72. 11 indexed citations

14.

Vezzosi, Delphine, A. Bennet, F. Courbon, & Philippe Caron. (2007). Short‐ and long‐term somatostatin analogue treatment in patients with hypoglycaemia related to endogenous hyperinsulinism. Clinical Endocrinology. 68(6). 904–911. 44 indexed citations

15.

Bourguet, P., François Planchamp, Françoise Montravers, et al.. (2006). [Recommendation for clinical practice: use of PET-FDG in cancer of the kidney, prostate, testicles, and the urinary bladder].. PubMed. 93(12). 1228–32. 5 indexed citations

16.

Bourguet, P., François Planchamp, Françoise Montravers, et al.. (2006). Bulletin de synthèse de veille 2006 Recommandations pour la pratique clinique : utilisation de la TEP-FDG dans les cancers du rein, de la prostate, du testicule et de la vessie. Bulletin du Cancer. 93(12). 1228–1232. 4 indexed citations

17.

Courbon, F., et al.. (2006). Preparation and Use of ¹³¹ I Magic Gel as a Dosimeter for Targeted Radionuclide Therapy. Cancer Biotherapy and Radiopharmaceuticals. 21(5). 427–436. 11 indexed citations

18.

Christian, Judith, Mike Partridge, Elena Nioutsikou, et al.. (2005). The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer. Radiotherapy and Oncology. 77(3). 271–277. 96 indexed citations

19.

Bourguet, P., M P Blanc-Vincent, A Boneu, et al.. (2003). Summary of the Standards, Options and Recommendations for the use of positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose (FDP-PET scanning) in oncology (2002). British Journal of Cancer. 89(S1). S84–S91. 25 indexed citations

20.

Plusquellec, Y., et al.. (1999). Consequence of equal absorption, distribution and/or elimination rate constants. European Journal of Drug Metabolism and Pharmacokinetics. 24(3). 197–203.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact